Stay updated on Autologous NK Cells and Isatuximab Maintenance Clinical Trial
Sign up to get notified when there's something new on the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page.

Latest updates to the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history shows a new revision v3.4.2 added and the previous v3.4.1 revision removed.SummaryDifference0.1%

- Check20 days agoChange DetectedA new revision entry (v3.4.1) was added to the record history and the previous revision (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI updates include showing a glossary and color-coded change indicators, and the revision note was updated to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedThe record history includes a new revision entry (v3.3.4) and removal of an existing entry (v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedNew entry Revision: v3.3.3 appears in the record history, and the HHS Vulnerability Disclosure item and Revision: v3.3.2 are removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Record History now includes a new revision entry v3.3.2 and removes revision v3.2.0; this is an administrative update to the history and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Autologous NK Cells and Isatuximab Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page.